380 related articles for article (PubMed ID: 20454597)
1. Human copper transporters: mechanism, role in human diseases and therapeutic potential.
Gupta A; Lutsenko S
Future Med Chem; 2009 Sep; 1(6):1125-42. PubMed ID: 20454597
[TBL] [Abstract][Full Text] [Related]
2. The roles of copper transporters in cisplatin resistance.
Kuo MT; Chen HH; Song IS; Savaraj N; Ishikawa T
Cancer Metastasis Rev; 2007 Mar; 26(1):71-83. PubMed ID: 17318448
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B.
Dmitriev OY
Biochem Cell Biol; 2011 Apr; 89(2):138-47. PubMed ID: 21455266
[TBL] [Abstract][Full Text] [Related]
4. Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.
Kalayda GV; Wagner CH; Buss I; Reedijk J; Jaehde U
BMC Cancer; 2008 Jun; 8():175. PubMed ID: 18565219
[TBL] [Abstract][Full Text] [Related]
5. Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin.
Huang CP; Fofana M; Chan J; Chang CJ; Howell SB
Metallomics; 2014 Mar; 6(3):654-61. PubMed ID: 24522273
[TBL] [Abstract][Full Text] [Related]
6. Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.
Leonhardt K; Gebhardt R; Mössner J; Lutsenko S; Huster D
J Biol Chem; 2009 Mar; 284(12):7793-802. PubMed ID: 19141620
[TBL] [Abstract][Full Text] [Related]
7. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human solid carcinomas.
Katoh R; Takebayashi Y; Takenoshita S
Ann Thorac Cardiovasc Surg; 2005 Jun; 11(3):143-5. PubMed ID: 16030471
[No Abstract] [Full Text] [Related]
8. Sec61β controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A.
Abada PB; Larson CA; Manorek G; Adams P; Howell SB
Mol Pharmacol; 2012 Sep; 82(3):510-20. PubMed ID: 22710939
[TBL] [Abstract][Full Text] [Related]
9. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
[TBL] [Abstract][Full Text] [Related]
10. The role of Ctr1 and Ctr2 in mammalian copper homeostasis and platinum-based chemotherapy.
Öhrvik H; Thiele DJ
J Trace Elem Med Biol; 2015; 31():178-82. PubMed ID: 24703712
[TBL] [Abstract][Full Text] [Related]
11. The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease.
Wee NK; Weinstein DC; Fraser ST; Assinder SJ
Int J Biochem Cell Biol; 2013 May; 45(5):960-3. PubMed ID: 23391749
[TBL] [Abstract][Full Text] [Related]
12. [Structure and function of ATP7A and ATP7B proteins--Cu-transporting ATPases].
Lenartowicz M; Krzeptowski W
Postepy Biochem; 2010; 56(3):317-27. PubMed ID: 21117320
[TBL] [Abstract][Full Text] [Related]
13. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs.
Safaei R; Howell SB
Crit Rev Oncol Hematol; 2005 Jan; 53(1):13-23. PubMed ID: 15607932
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of the metal binding domains and regulation of the human copper transporters ATP7B and ATP7A.
Yu CH; Dolgova NV; Dmitriev OY
IUBMB Life; 2017 Apr; 69(4):226-235. PubMed ID: 28271598
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
Samimi G; Howell SB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
[TBL] [Abstract][Full Text] [Related]
16. Role of copper transporters in resistance to platinating agents.
Rabik CA; Maryon EB; Kasza K; Shafer JT; Bartnik CM; Dolan ME
Cancer Chemother Pharmacol; 2009 Jun; 64(1):133-42. PubMed ID: 18998134
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
Mangala LS; Zuzel V; Schmandt R; Leshane ES; Halder JB; Armaiz-Pena GN; Spannuth WA; Tanaka T; Shahzad MM; Lin YG; Nick AM; Danes CG; Lee JW; Jennings NB; Vivas-Mejia PE; Wolf JK; Coleman RL; Siddik ZH; Lopez-Berestein G; Lutsenko S; Sood AK
Clin Cancer Res; 2009 Jun; 15(11):3770-80. PubMed ID: 19470734
[TBL] [Abstract][Full Text] [Related]
18. Roles and mechanisms of copper transporting ATPases in cancer pathogenesis.
Zhang Y; Li M; Yao Q; Chen C
Med Sci Monit; 2009 Jan; 15(1):RA1-5. PubMed ID: 19114980
[TBL] [Abstract][Full Text] [Related]
19. Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis.
La Fontaine S; Mercer JF
Arch Biochem Biophys; 2007 Jul; 463(2):149-67. PubMed ID: 17531189
[TBL] [Abstract][Full Text] [Related]
20. Cross-resistance to cisplatin in cells with acquired resistance to copper.
Safaei R; Katano K; Samimi G; Naerdemann W; Stevenson JL; Rochdi M; Howell SB
Cancer Chemother Pharmacol; 2004 Mar; 53(3):239-46. PubMed ID: 14648017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
